Session: Engineering Stem Cell Therapy II (2012 Annual Meeting)

Description:

Stem cell research holds enormous potential for contributing towards treatment and ultimately cure for many diseases for which adequate therapy does not exist. This session focuses on utilizing stem cell for therapeutic applications in particular through bioengineering approaches. Basic understanding of stem cell behavior as well as translational studies using embryonic stem cells, induced pluripotent cells or tissue specific stem cells is of interest to this session. Topics of interest include but are not limited to: novel methods for propagation and/ or tissue specific differentiation; novel agents or biomaterials for propagation and/ or tissue specific differentiation; systems level modeling to understand stem cell behavior; signaling pathways involved in stem cell propagation and/ or differentiation.

Sponsor:

Biomedical Applications of Chemical Engineering

Co-Sponsor(s):

Engineering Fundamentals in Life Science (15d)

Chair:

Ipsita Banerjee
Assistant Professor
University of Pittsburgh
Chemical and Petroleum Engg
1242 Benedum Hall
Pittsburgh, PA 15261
Fax Number: 412-624-9639
Email: ipb1@pitt.edu

Co-Chair:

Shyni Varghese
Assistant Professor
University Of California, San Diego
Bioengineering
9500 Gilman Drive
La Jolla, CA 92093
Fax Number: 858-534-5722
Email: svarghese@ucsd.edu

Papers:

558a

Towards Ex Vivo Platelet Manufacturing: The Importance of Matrix Elasticity and Shear Force On Megakaryocytic Differentiation
Jinlin Jiang, University of Delaware; Stephan C. Lindsey, University of Delaware; Eleftherios T. Papoutsakis, University of Delaware

558b

Cardiac Tissue Engineering Using Human Pluripotent Stem Cells
Tung Ying Lu, University of Pittsburgh; Bo Lin, University of Pittsburgh; Lei Yang, University of Pittsburgh

558c

Stem Cell Senescence: Nanog Reverses the Effects of Organismal Aging On Proliferation and Myogenic Differentiation Potential of Mesenchymal Stem Cells
Juhee Han, University at Buffalo, the State University of New York; Panagiotis Mistriotis, University at Buffalo, State University of New York; Stelios T. Andreadis, University at Buffalo, the State University of New York

558d

Multiplexed Single Cell Analysis of Embryonic Stem Cells and Induced Pluripotent Stem Cells
Jun Wang, California Insitute of Technology; Ritchie Hor, UCLA; Kathrin Plath, UCLA; James Heath, California Institute of Technology

558e

Neural Stem Cell 3D Neuronal Differentiation in Fluorinated Methacrylamide Chitosan Hydrogels
Hang Li, The University of Akron; Asanka Wijekoon, ARL BioPharma Inc.; Nic D. Leipzig, The University of Akron

558f

Cytosolic Delivery of Reprogramming Factors with a Microfluidic Device
Nahyun Cho, MIT

See more of this Group/Topical: Topical 7: Biomedical Applications of Chemical Engineering

<< Previous Session | Next Session >>